Ask AI
Case Challenge: Colorectal Cancer

CE / CME

Biomarker Testing in Patients With Solid Tumors: Interactive Case Challenge for Colorectal Cancer

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hours, includes 0.50 hour of pharmacotherapy credit

Released: May 19, 2026

Expiration: November 18, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Beginning at what point in the disease continuum of colorectal cancer (CRC) is it currently standard of care to recommend that patients should undergo broad molecular profiling, preferably using next-generation sequencing, to guide treatment decision?

2.

Which BRAF inhibitor would you tell a patient is indicated in combination with cetuximab as a treatment option for metastatic CRC and a confirmed BRAF V600E mutation?

3.

Which of the following biomarkers can help inform treatment decisions in a patient diagnosed with stage III CRC?